Podcasts about Psoriasis

In this 2-part series, Jennifer Winstead shares her incredible story with Sue Becker about how switching to freshly-milled flour helped completely transform her health. After years of struggling with severe IBS, autoimmune challenges, and dental issues following Accutane use, Jennifer discovered the healing power of nourishing her body with Real Bread. Hear how her journey of restoration gave her hope—and ultimately gave her life. Topics on this episode: Accutane, dermatology, Irritable Bowel Syndrome (IBS), Fibromyalgia, Lupus, Psoriasis, dental, detox LISTEN NOW and SUBSCRIBE to this podcast here or from any podcasting platform such as, Apple Podcasts, YouTube, Spotify, Alexa, Siri, or anywhere podcasts are played. Follow Jennifer Winstead and hear more of her story

Board-certified dermatologists Dr. Ted Lain and pediatric dermatology expert Dr. Lisa Swanson break down the latest pediatric dermatology treatments in this episode of the Science of Skin Podcast. Topics covered: atopic dermatitis (eczema) treatment updates including Zoryve, Vtama, and Opzelura; pediatric psoriasis therapies including Zoryve foam, Tremfya, and the oral IL-23 inhibitor Sotyktu; GLP-1 medications (Ozempic/semaglutide) for psoriasis and hidradenitis suppurativa; spironolactone dosing for teenage female acne; hemangioma treatment with timolol, propranolol (Hemangiol), and nadolol; molluscum contagiosum treatment with Ycanth and berdazimer gel (Zelsuvmi); and JAK inhibitors (Litfulo, Olumiant, Rinvoq) for pediatric alopecia areata and early intervention strategies. Plus: a lighthearted dive into Bachelor Nation, Secret Lives of Mormon Wives, Love Island, and Taylor Swift's wedding buzz. Send episode topic ideas to questions@scienceofskinsummit.com. Subscribe and leave a 5-star rating to support the show. Join us at the Science of Skin Summit, September 17–20 in Austin, Texas, and the Longevity Conference, February 19–21 in Scottsdale, Arizona. Learn more at scienceofskinsummit.com. Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.

It's easy to blame yourself when medications like Dupixent, Adbry, or Ebglyss don't work (or work well enough), your doctor says that you've “failed” it and it's time to move on to something else. Very often, no one is asking, "Why wasn't Dupixent able to work in the first place?" which could uncover important clues about your eczema case potentially lurking under the surface.Because YOU didn't fail the drug, and before moving on to something else, this is what you absolutely need to consider.Plus, we'll talk about a little-known warning in the safety information for Dupixent and other IL-13-blocking biologics specifically about parasites. So let's dive into what I've seen in clients prescribed these medications and why what looks like drug failure to their doctor could be an important root cause clue.⭐️Mentioned in This Episode:- See all the references

Injection against Psoriasis today, need to know the source by Anna Virginius

Dealing with the heat - Europeans' disdain for air conditioningI have scaly and bumpy areas on my scalp that itch!Did homeopathic human growth hormone increase my cholesterol?

Delivra Health Brands CEO Gord Davey joined Steve Darling from to discuss the launch of LivRelief Itch Cream, a new product designed to help relieve itchiness associated with eczema, psoriasis, dermatitis, and other common skin irritations. Davey said the cream is formulated for sensitive skin and is hypoallergenic, fragrance-free, and free from parabens, petroleum, and SLS. The product combines Hydrocortisone, Calendula, and Chamomile to help reduce itching, irritation, and inflammation. In addition to eczema and psoriasis-related discomfort, LivRelief Itch Cream can also be used for the temporary relief of minor skin irritations such as rashes, redness, insect bites, poison ivy, poison oak, and poison sumac. Management says the launch targets a large and underserved market. According to the Canadian Dermatology Association, up to 17% of Canadians will experience atopic dermatitis at some point in their lives. Davey also pointed to the Eczema Society of Canada's 2025 survey, which found that 89% of respondents identified itch reduction as a key treatment goal, while 86% wanted better control of rash and skin symptoms. In addition, Psoriasis Canada estimates that more than one million Canadians are affected by psoriasis and psoriatic arthritis. Delivra believes the new LivRelief Itch Cream expands its topical wellness and pain-relief portfolio while addressing a clear consumer need for effective, accessible, and skin-friendly itch relief solutions. #proactiveinveestors #delivrahealthbrandsinc #tsxv #dhb #otcqb #dhbuf #DreamWater #GlobalExpansion #DreamWater #LivRelief #CBD #Cannabis #Wellness #Topicals #Canada #ConsumerGoods #LivRelief #Healthcare #CannaTech

Many people turn to probiotics hoping they'll improve both their gut health and even their skin. But what if your digestive symptoms (or that skin rash) actually get worse after starting them? In this episode, I explain what a reaction to probiotics means, why it shouldn't just be viewed as "die-off", and what it says about your gut health.We'll also explore the truth about probiotic side effects, why probiotics aren't the right fit for everyone, and how hidden gut imbalances can change the way your body responds. If you've ever wondered whether you should keep taking a probiotic that's making you feel worse, this episode will help you understand what's really going on and what steps to take next.⭐️Mentioned in This Episode:- See all the references

Looking for the run down on mast cells? We've got you covered. This week, we're joined by Dr. Sonal Choudhary as she walks us through Mast Cell Activation Syndrome. Listen in as she discusses the difficulty of diagnosis, what makes it controversial, and the latest science of MCAS. Each Thursday, join Dr. Raja and Dr. Hadar, board-certified dermatologists, as they share the latest evidence-based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com. Sonal Choudhary, MD is a Board certified Dermatologist and fellowship trained Dermatopathologist, who joined the Department of Dermatology in 2016 upon completion of her Dermatopathology Fellowship at the University of Pittsburgh. Dr. Choudhary received her undergraduate degree and medical degree from Vardhman Mahavir Medical College in New Delhi India. She completed a post-doctoral research fellowship at the University of Miami, where she remained to complete her Preliminary Internship in Internal Medicine, as well as her Residency Program in Dermatology. Dr. Choudhary is also undergoing a fellowship in Integrative Dermatology which will conclude in February of 2024.   While she offers care for all dermatologic conditions, Her areas of clinical interest and research are atopic dermatitis, gut and skin microbiome, integrative dermatology, alternative therapies and approaches (herbs, supplements, functional medicine testing) to inflammatory skin diseases (Hidradenitis suppurativa, Acne, Psoriasis, hair loss), nutrition in cutaneous disease and dermatopathology. She is the director of the adult atopic dermatitis clinic, expert team member on hEDS/HSD group and member of the PCOS collaboration group at UPMC Magee. Given her areas of training, Dr. Choudhary offers a holistic and integrative approach for various skin conditions. She has extended collaborations with departments and specialties outside of Pitt Dermatology, such as Carnegie Mellon University Robotics Engineering department.   Dr. Choudhary is very well published and has authored articles published in high impact journal on a wide spectrum of dermatological disease states and management approaches. Her publications can be reviewed on pubmed. She is constantly involved in training the next generation of physicians from medical students, residents (dermatology and medicine), fellows and Physician assistants under her supervision. Professional memberships Member of Integrative Dermatology with Integrative Dermatology Certification Program/LearnSkin Fellow of Pittsburgh Academy of Dermatology Fellow of Pennsylvania Academy of Dermatology Fellow of American Academy of Dermatology Fellow of American Academy of Dermatopathology Education & Training MBBS, Vardhman Mahavir Medical College, Safdarjung Hospital, New Delhi, India Clinical Internship, Vardhman Mahavir Medical College, Safdarjung Hospital, New Delhi, India Post Doctoral Fellowship, University of Miami Miller School of Medicine Internship, University of Miami and Jackson Memorial Hospital Residency, Dermatology, University of Miami and Jackson Memorial Hospital Fellowship, Dermatopathology, University of Pittsburgh Medical Center Fellowship, Integrative Dermatology

Dr. Ted Lain sits down with board-certified pediatric dermatologist Dr. Nnenna Agim to discuss the toddler indication for roflumilast cream (Zoryve) and how non-steroidal topicals are changing the treatment landscape for atopic dermatitis, psoriasis, and seborrheic dermatitis in children. In this episode of the Science of Skin Podcast, Dr. Agim shares her real-world clinical experience using roflumilast cream 0.05% (ages 2-5) and 0.15% (ages 6+) as a steroid-sparing alternative for pediatric eczema, explaining why more families are requesting non-steroidal options from the start of treatment. The conversation covers: Why roflumilast (Zoryve) is safe to use on any body surface, including the face and skin folds Managing parent expectations and proper dosing to avoid overuse The importance of pairing roflumilast with ceramide-rich, fragrance-free moisturizers like CeraVe, La Roche-Posay, and Vaseline How roflumilast compares to crisaborole (Eucrisa) and topical corticosteroids in tolerability Treating psoriasis and seborrheic dermatitis in children with roflumilast foam and cream Skin barrier repair, ceramide production, and the role of the acid mantle in atopic dermatitis Caring for textured hair and scalp conditions in pediatric patients Real patient outcomes and quality-of-life improvements with Zoryve This episode is sponsored by Arcutis Biotherapeutics and is part of an ongoing series exploring roflumilast formulation science. Don't miss the related episode on roflumilast's formulation with Dr. Chris Bunick. Learn more about the Science of Skin Summit (Austin, TX) and the new Science of Skin Longevity Summit (Scottsdale, AZ, Feb 2027) at scienceofskinsummit.com.

Please visit answersincme.com/860/IME-020568-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Jeffrey M. Cohen, MD, MPH; Kristine Kucera, PA-C, MPAS, DHSc; and Lauren E. Miller, MPAS, PA-C. In this activity, experts in dermatology discuss the evolving role of next-generation TYK2 inhibitors in the treatment of patients with moderate to severe psoriasis. Upon completion of this activity, participants should be better able to: Explain the clinical rationale for TYK2 inhibitors in the management of patients with moderate to severe psoriasis; Differentiate the mechanism of action of TYK2 inhibition from other oral treatment options used for patients with moderate to severe psoriasis; and Apply available clinical evidence to identify patients with moderate to severe plaque psoriasis who may be appropriate candidates for TYK2 inhibitor therapy within current treatment paradigms. This activity is intended for US healthcare professionals only.

The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use, efficacy and side effects. Features Dr. Jack Cush, Editor at RheumNow.com. Show Notes: - Breckenridge Pharmaceutical received FDA approval for their generic version of tofacitinib on 6/4/26. 5 mg and 10 mg tablets are now available in the U.S. market, for both adult and pediatric use. Tofacitinib Tablets are manufactured in Martorelles, Spain. https://t.co/oAh0KQSFgs - TB Infection or reactivation is Psoriasis or Psoriatic Arthritis pts taking IL-23 inhibitors is rare, rare. Literature review showed 34 studies of IL-23i in PsO had no new TB, but 1 case of LTBI reactivation. In 8 IL-23i PsA studies there were NO new TB or LTBI reactivations https://t.co/NFIap7DSOr   - BE BOLD: Bimekizumab Beats Risankizumab (LB0001) –H2H trial bimekizumab vs risankizumab in PsA for 24 weeks. At week 16; BKZ better than RZB,  p=0.0058). This advantage was maintained out to week 24 (55% vs 44%; p 0.0001). - RA-BRIDGE and RA-BRANCH: FDA mandated study of the risk of venous thromboembolic events (VTE) taking baricitinib (BARI) or TNF inhibitors. The incidence rate was 0.79/100 PY for BARI combined versus 0.51/100 PY for TNFi. The hazard ratio was 1.606 (95% CI 0.969–2.660), with the upper CI exceeding the pre-specified NI margin of 1.8.  Baricitinib (neither dose) was associated with a higher risk of MACE (HR 1.06), all-cause mortality (HR 0.97), arterial thromboembolism (HR 1.27), or opportunistic infections (HR 1.25).   - Probiotics in Psoriatic Arthritis. (POS0290)    66 PsA patients randomized to receive either placebo or probiotic containing lactobacillus and bifidobacterium strains for 12 weeks.  This trial proves no significant effect with oral probiotic supplementation in PsA.  - CLE and smoking. Smoking reduces efficacy of antimalarials & worsens dz activity & damage. Advocate for smoking cessation! @Rheumnow #EULAR2026 https://t.co/pEWLJAkBAJ - Risk of Psoriasis is increased 19% by long-term exposure to Particulate Matter (PM2.5 & PM10; adjHR 1.19), while short-term exposure increases risk of psoriasis exacerbation (adjusted OR 1.03). Stronger in younger, urban, lower SES, ever-smokers, & comorbid allergies https://t.co/pd6S13RG1B

Send us Fan MailFor decades, medicine has recognized that pregnancy and menopause transform nearly every system in the body. Yet only recently have researchers begun asking a simple question: what happens to chronic skin diseases like eczema and psoriasis during these major biological transitions? The answers may reveal one of the biggest blind spots in modern medicine.Dr. Doral Fredericks, PharmD, MBA is Vice President and Head of Global Medical Affairs and Outcomes Research at Organon ( https://www.organon.com/ ), a global healthcare company focused on improving women's health throughout every stage of life.With nearly three decades of experience spanning clinical pharmacy, pharmaceutical development, medical affairs, and healthcare strategy, Dr. Fredericks has held senior leadership roles across some of the world's leading healthcare organizations, including Organon, Dermavant Sciences, ACADIA Pharmaceuticals, Bausch + Lomb, Novartis, AstraZeneca, and Kaiser Permanente.Throughout her career, Dr. Fredericks has led global medical affairs organizations, overseen clinical development programs, real-world evidence generation, physician education initiatives, and outcomes research efforts across multiple therapeutic areas. Her work has focused on translating scientific innovation into meaningful improvements in patient care while helping healthcare systems better understand the unique needs of diverse patient populations.Today, Dr. Fredericks is helping drive a growing conversation around female dermatology - a field examining how major biological transitions such as pregnancy, postpartum recovery, perimenopause, and menopause can profoundly influence chronic skin diseases including eczema, psoriasis, and other inflammatory conditions.On this episode, we'll explore why women's skin health remains an underrecognized area of medicine, how hormonal and immune changes across a woman's lifespan affect dermatologic disease, and what the future of personalized care may look like as researchers begin paying closer attention to the unique biology of female patients.#WomensHealth #Dermatology #Menopause #Psoriasis #Eczema #SkinHealth #Healthcare #PrecisionMedicine #AutoimmuneDisease #Hormones #Postpartum #PregnancyHealth #MedicalResearch #Inflammation #Medicine #Organon #Dermatologist #HealthyAging #Longevity #HealthcareInnovation #SciencePodcast #MedicalScience #FutureOfMedicine #SkinDisease #ProgressPotentialPossibilitiesSupport the show

Hear from dermatologist Dr. Ron Prussick and cardiologist Dr. Brittany Weber as they discuss the emerging role of GLP-1 receptor agonists in the management of patients with psoriasis. This conversation explores the intersection of psoriatic disease, obesity, and cardiometabolic health, and how these therapies may support improved outcomes. Learn more about the National Psoriasis Foundation's GLP-1 Primer for Dermatologists: https://www.psoriasis.org/glp-1-primer-for-dermatologists/ Key Takeaways Patients with higher BMI have a lower likelihood of achieving PASI 90 and 100 and a higher risk of developing PsA and other comorbidities. Psoriasis is linked to increased cardiovascular risk, and GLP-1 therapies can address multiple drivers at once, including adiposity, cardiometabolic dysfunction, and inflammatory burden. Patients with psoriasis or psoriatic arthritis who also have metabolic comorbidities such as obesity, insulin resistance, fatty liver disease, or diabetes, as well as related conditions like hidradenitis suppurativa, may be strong candidates for adding GLP-1 agonists alongside standard psoriasis therapies. This podcast is supported in part by Lilly. 

The post From Endpoint to Exam Room: Understanding What Psoriasis Trials Really Tell Us appeared first on JDDonline - Journal of Drugs in Dermatology.

While the carnivore diet has helped some people improve gut, skin, and autoimmune symptoms, it's not always the success story social media makes it out to be. In this episode, you'll hear about unexpected problems that can arise and why some people experience worsening symptoms and rashes on the diet.If you've wondered about potential carnivore diet side effects, this conversation offers a perspective you may not have heard before. And learn how carnivore can impact your gut microbiome the longer you follow it and whether it will actually stop candida overgrowth.⭐️Mentioned in This Episode:- See all the references

Qué Temas Quieres Escuchar Toca y Hablemos. TE LEO.Muchas personas pasan años aplicando cremas, tomando medicamentos o probando distintos tratamientos para controlar problemas de piel que parecen no desaparecer. Al principio algunos funcionan, pero con el tiempo los síntomas regresan y comienza una búsqueda constante de nuevas soluciones.Cuando esto ocurre, pocas personas se preguntan qué está sucediendo realmente detrás del problema. ¿Es posible que el tratamiento se convierta en parte del problema? ¿Y qué consecuencias podría tener intentar controlar los síntomas durante años sin abordar la causa de fondo?En este episodio de “Cómo Curar”, junto a Michelle Peiret exploramos una realidad con la que muchas personas se sentirán identificadas: la frustración de probar una cosa tras otra sin encontrar respuestas duraderas. También hablamos sobre algunos tratamientos ampliamente utilizados y por qué, en ciertos casos, pueden terminar convirtiéndose en un círculo difícil de romper.En este episodio conversamos sobre:• El uso prolongado de esteroides y corticoides • Por qué algunos tratamientos dejan de funcionar con el tiempo • Problemas de piel que afectan la autoestima y la calidad de vida • Qué ocurre cuando el tratamiento de los síntomas deja de ser suficienteDisfruta de este episodio y muchos más en ComoCurar.com, en tu plataforma de podcast favorita o en YouTube, en el canal Cocó March N.M.D.#DraCocoMarch #TipsCocoMarch #CocoMarch #SaludDeLaPiel #Psoriasis #Rosacea #Melasma #Acne #Dermatitis #Corticoides #Esteroides #InflamacionCronica #PielSana #CuidadoDeLaPiel #SistemaInmune #EnfermedadesDeLaPiel #Episodio163 #Temporada4 #ComoCurarConsigue mis fórmulas en USA y México: https://store.dracocomarch.com/es/Consigue mis fórmulas en Europa:https://vitatiendaeuropa.com/es/Visita mi Podcast:https://comocurar.com/Sígueme en redes:https://www.facebook.com/CocoMarchNMDhttps://www.instagram.com/cocomarch.nmd/https://www.youtube.com/@CocoMarchNMDhttps://www.tiktok.com/@coco.march.nmd Aprende de mi blog:https://blog.dracocomarch.com

In this episode of the DIGA Podcast, we continue our Dermatology Crash Course mini series with a high-yield discussion on Psoriasis led by Dr. Nikki Trupiano. We hope you enjoy!About the Dermatology Crash Course Series The Dermatology Crash Course is a DIGA Podcast mini-series focused on delivering short, high-yield episodes that cover foundational dermatology topics. Each episode features a dermatologist sharing practical insights to help learners develop confidence in recognizing and managing common skin conditions.Learn More:Educational links: AAD Educational ModulesConnect with Dr. Trupiano:Instagram: @nikki_trupianoEmail: nikki.trupiano@northwestern.edu---DIGA Instagram: @derminterestToday's Host, George: @georgepapadeas---For questions, comments, or future episode suggestions, please reach out to us via email at derminterestpod@gmail.com ---District Four by Kevin MacLeodLink:https://incompetech.filmmusic.io/song/3662-district-fourLicense:https://filmmusic.io/standard-license---

Are peptides safe? And is it possible that with their growing interest for everything from injury recovery and exercise performance to weight management and healthy aging, it's no surprise that important drawbacks are overlooked? Like could peptides fuel cancer growth?That's why it may be increasingly risky to overlook key factors like lab testing, inflammation, and individual health history when deciding if peptides are right for you. My guest, Dr. Elena Zinkov, is a naturopathic medical doctor and entrepreneur who specializes in hormone optimization, longevity, and regenerative medicine. With a science-backed approach to healthspan, she is passionate about helping women access personalized solutions that support vitality and well-being at every stage of life.⭐️Mentioned in This Episode:- See all the references

The kidneys are a major detox organ and are often overlooked or ignored entirely by most practitioners. In this episode I chat about the importance of the kidneys, how they work, signs they may need a detox and detos and drainage tips.Equip Grass fed protein: www.equipfoods.com/MARLA60 Day Gut Reset ($200 OFF) - https://checkout.teachable.com/secure/1716725/checkout/order_52y48hdz?coupon_code=SECRETOFFER

2026 EULAR Preview Imaging in Subclinical Psoriatic Arthritis Dietary Interventions in PsA This Is a Woman's World: Women's Health in Rheumatic Disease Impact of Synovial Biopsy-Driven Therapeutic Stratification in PsA Can We Stop PsA Before it Starts? BE BOLD: Going Where No PsA Trial Has Gone Before BMI Outranks Treatment in PsA Outcomes? Debate: Combination Therapies for Inflammatory Arthritis? Combination Biologics in PsA: MRI Findings from AFFINITY Combination Therapy in SpA The Case for Dual Pathway Blockade in Refractory PsA The AFFINITY Study: Combination Treatment in PsA PsA Potpourri: Probiotics & Head-to-Head Data Transition from Psoriasis to Psoriatic Arthritis MACE and Safety Profile of bDMARDs/JAKis in axSpA and PsA Guselkumab Delivers Across the PsA Disease Spectrum: APEX Trial  

Think you'd know if you had parasites? Many people assume parasite symptoms are obvious, like severe diarrhea or illness after international travel. But as this episode reveals, parasites can show up in unexpected ways, including constipation, chronic skin rashes, and symptoms unrelated to digestion.Join me to unpack three common parasite myths that you cannot trust. And believing in them keeps you from healing while distracting you from important clues in your own health journey. You'll learn why you can't trust negative test results, how past travel can be a major clue, and commonly missed parasite signs that many functional practitioners blame on other problems.⭐️Mentioned in This Episode:- Want personalized help to fix your skin (especially if you suspect parasites)? Get started here with Jennifer's virtual clinic

Debate: Combination Therapies for Inflammatory Arthritis? Combination Biologics in PsA: MRI Findings from AFFINITY Combination Therapy in SpA Digital Patient Education in RA The Case for Dual Pathway Blockade in Refractory PsA The AFFINITY Study: Combination Treatment in PsA PsA Potpourri: Probiotics & Head-to-Head Data Transition from Psoriasis to Psoriatic Arthritis  

Description:  How do GLP-1 receptor agonists or GIP agonists work and what is the impact for my psoriatic disease? Hear dermatologist Dr. Ronald Prussick and cardio-immunologist Dr. Brittany Weber answer such questions and more.           Join host Archie Franklin as he takes a deep dive into the use of GLP-1 receptor agonists and GIP agonists and the convergence of systemic inflammation related to psoriatic disease with renowned dermatologist and Vice Chair of the NPF Medical Board, Dr. Ronald Prussick from Washington Dermatology Center in Rockville and Frederick, MD, and, cardio-immunologist Dr. Brittany Weber, Director of the Cardio-Rheumatology/ Cardio-Dermatology Program at the University of Texas Southwestern. Learn more about the use of incretin hormones, the impact of weight management on psoriatic disease, metabolic and cardiovascular risk, as well as results from the TOGETHER-Pso and TOGETHER-PsA clinical trials.  This episode addresses the actions of incretin hormones (GLP-1 receptor agonist and GIP agonist) and how such use may be beneficial in the management of inflammation related to psoriasis and psoriatic arthritis.  Thank you to Lilly for their support of this program activity.  Timestamps: (0:00)  Intro to Psoriasis Uncovered & guest welcome dermatologist Dr. Ronald Prussick and cardio-immunologist Dr. Brittany Weber.  (1:35)  What are incretin hormones and how GLP-1 or GIP receptor agonists (RA) inhibit appetite to initiate weight loss. (3:29)  Why GLP-1 RAs are of interest in the management of psoriasis and psoriatic arthritis. (5:23)  The metabolic, cardiovascular, and psoriatic disease convergence. (7:19)  Will reduction of inflammation impact cardiovascular risk? (10:59) Treatment challenges associated with having psoriatic disease and being overweight or obese. (13:45)  Key points around the use of GLP-1 receptor agonists when managing psoriasis and psoriatic arthritis. (17:06)  Results of the TOGETHER-PsO and TOGETHER-PsA phase 3 clinical trials combining use of an IL-17 inhibitor and a GIP and GLP-1                receptor agonist therapy. (19:07)  Having the conversation of adding a GLP-1 RA medication to a treatment regimen. (22:40)  The paradigm shift of GLP-1 receptor agonists and the impact they can have on shared inflammatory pathways. Key Takeaways: ·       Glucagon-like peptide-1 (GLP-1) receptor agonists and glucose-dependent insulinotropic polypeptide (GIP) agonists are two incretin hormones that assist in managing excess body weight -- which as a result can be helpful in managing inflammation in the body.   ·       Psoriasis isn't just a skin and joint disease. It's a complex network of systemic inflammation with shared inflammatory pathways that worsens with increased weight impacting the severity of the disease, and accelerates the risk of metabolic dysfunction, and cardiovascular disease.   ·       The best outcomes occur as a result of multidisciplinary collaboration to address the impact of excess weight and systemic inflammation. If you are struggling to lose weight with diet and exercise, speak with your medical team about your options including the use of GLP-1 or GIP agonists.   Guest Bios: Renowned dermatologist Ronald Prussick, M.D., Medical Director of the Washington Dermatology Center in Rockville and Fredrick, Maryland, specializes in the treatment of psoriasis along with other diseases of the skin, hair, and nails. Dr. Prussick is also a Clinical Associate Professor in Dermatology at George Washington University in Washington, D.C.. Dr. Prussick has a research interest in the impact of diet on psoriatic disease and metabolic health, first becoming interested after being involved in Dr. Joel Gelfand and Dr. Nehal Mehta's work in vascular inflammation trials using FDG-PET/CT scans to view systemic and cardiovascular inflammation associated with psoriatic disease. Dr. Prussick has since participated in the development of the 2018 Dietary Recommendations for Adults with Psoriasis or Psoriatic Arthritis and more recently the position statement "GLP-1 Receptor Agonists in Psoriasis: A Primer from the National Psoriasis Foundation Medical Board". Dr. Prussick is Vice Chair of the NPF Medical Board which provides clinical direction, treatment guidance, and education oversight to the organization and its Executive leaders.  Brittany Weber, M.D., Ph.D. is a cardio-immunologist who is the Director of the Cardio-Rheumatology/ Cardio-Dermatology Program at the University of Texas Southwestern. She is also a member of the Division of Cardiology, a clinical investigator, and imaging specialist. Dr. Weber's research integrates advanced imaging, molecular biology, clinical trials, and population health to understand how systemic inflammation and immune deregulation drives cardiovascular dysfunction. Prior to joining UT Southwestern in 2025, Dr. Weber served on the faculty at Harvard Medical School and was the Director of the Cardio-Rheumatology Clinic at Brigham and Women's Hospital, a nationally recognized clinic addressing inflammation-related heart disease through collaborative, patient centered care. Dr. Weber is also an author on the position statement "GLP-1 Receptor Agonists in Psoriasis: A Primer from the National Psoriasis Foundation Medical Board". Resources: "The Metabolic Collison and How You Can Take Control with Psoriatic Disease" podcast episode with dermatologist Dr. Ronald Prussick and registered dietitian Danielle Cahalan   "NPF Medical Board Issues GLP-1 Primer for Dermatologists" Press Release "Finding My Path to Managing Psoriatic Disease and Excess Weight" podcast episode featuring dermatologist Dr. Erin Boh, patient advocate Brian Lehrschal, and moderator Jennifer Bomberger. 

Michele Scarlet sits down with RN, Nurse Practitioner, and Functional Diagnostic Nutrition Practitioner Connie Wade for an honest conversation about what 25 years inside the emergency room taught her about the limits of conventional medicine, why her own doctor told her she was not "sick enough" to treat, and how she finally healed the symptoms she had been "swiping away" for years. In this powerful Health Detective Podcast episode, Connie shares her personal journey through psoriasis, debilitating joint pain at 48, chronic reflux, daily ibuprofen use, estrogen dominance, heavy painful periods, more than 20 years of night shift, H. pylori, an overwhelmed liver and gallbladder, food sensitivities to her favorite foods, and a depleted gut microbiome. Together, Michele and Connie unpack how functional lab testing gave Connie the vindication she had been looking for, why she healed in three months once she addressed the root causes, and why she chose to keep working in the ER while building her functional health practice on the side. This episode dives deep into: Why her doctor said "she wasn't sick enough" and sent her home with ibuprofen The functional labs that finally explained her symptoms after years of being dismissed How 20 plus years of night shift flatlined her cortisol and disrupted her hormones H. pylori, food sensitivities, and the gut findings that changed everything Why psoriasis, joint pain, and heavy periods are not just "normal aging" The reframe that helped Connie cut gluten, sugar, and dairy without feeling deprived Why so many nurses are leaving bedside nursing and the third option most do not consider How to build a functional nursing side practice without leaving your license or your job Why going all in or all out of conventional medicine limits your reach as a clinician The four simple daily practices Connie recommends to every patient How to ask your family for support when you start your healing journey Michele and Connie also discuss why the body is constantly trying to send messages, why most of us swipe them away for years, and why functional lab testing catches dysfunction long before conventional labs ever turn "abnormal." If you are a woman struggling with joint pain, psoriasis, hormone imbalance, or symptoms your doctor keeps dismissing, or you are a nurse, NP, or clinician quietly exploring functional medicine as a career path, this episode will change how you view your body and what is possible.

This podcast episode features a powerful role reversal as host Sarah Dawkins, author of Heal Yourself and a registered nurse, steps into the interviewee seat. Guest host Bethany Shipley explores Sarah's journey from the front lines of cardiothoracic nursing to becoming a global advocate for natural self-healing.Episode OverviewSarah spent years on the front lines of surgery, surrounded by the best medicine money could buy. But while she was saving lives, her own body was falling apart. Psoriasis, depression, PTSD and chronic pain.Sarah didn't just find a new prescription, she found a new path. Meet Sarah Dawkins: The nurse who stopped following orders, defied her training and healed herself. We're diving into the "crisis of conscience" that changed everything.Why Listen?If you have ever felt "sick and tired of being sick and tired," this episode offers a roadmap of hope. Sarah's story proves that healing isn't just for a "special" few, it is a possibility for anyone willing to listen to their body and step outside their comfort zone.Key Topics & Timestamps02:10 The specific 2005 encounter in a Florida hospital that challenged Sarah's beliefs about pharmaceuticals.02:54 Navigating a deep depression and the "crisis of conscience" while working in cardiothoracic surgery.03:53 Why Sarah hid her book for 5 years and how she eventually gathered 74 contributors to provide "social proof" that healing happens.07:01 The moment Sarah was reported to the nursing board for sharing her natural thyroid healing journey.09:42 A list of the physical conditions Sarah healed, from psoriasis and acid reflux to chronic joint pain and PTSD.12:06 An honest look at bulimia, emotional eating, and how "disgust" became a catalyst for change.18:05 Sarah's simple rule: "If I don't buy it, I can't eat it."20:34 The "Single-Ingredient Food" strategy for feeding picky kids and busy families.24:29 Why Sarah chose to bypass traditional publishing to get the message to the public faster.28:02 Understanding the metaphysical link between "frozen shoulders" and carrying the weight of the world.29:51 How spinal pain often correlates to feelings of financial or personal insecurity.31:41 Using short meditations to stop "checking out" via food, alcohol, or scrolling.33:45 Why we are afraid to trust our own feelings and how to stop seeking external approval.Bethany's Bio Bethany Shipley is a writer, speaker, and philosophical guide for people who are ready to live a life that is true to them.Her work centers around a powerful idea: Being influences Doing. When you understand who you are at your core and have the courage to live from that place, your actions naturally align and your life begins to reflect something deeply authentic.Bethany is known for blending grounded insight with spiritual depth, helping people reconnect to their instinct, expression, and internal compass. She moves beyond hype and surface-level encouragement, guiding people into a lived experience of alignment.Through her podcast, Market Your Personal Brand and upcoming book, she empowers and inspires people to live an authentic life.Connect with Bethany https://www.bethanyshipley.com/Who am I?Sarah Dawkins is a passionate Holistic Health and Healing Coach, international speaker and author of Heal Yourself. She's also a multi-award-winning entrepreneur and the award-winning host of the uplifting podcast Mind Body Medicine for Self Healers with Sarah Dawkins.With over 20 years' experience as a Registered Nurse, Sarah combines her deep understanding of conventional medicine with her own powerful self-healing journey to create a truly integrative approach. Having overcome multiple chronic health challenges herself, she now supports others in uncovering and addressing the root causes of their symptoms, helping them restore balance, reclaim their energy and create lasting, vibrant wellness.www.sarahdawkins.com

Dr. Marty Makary out as FDA Commissioner—was he the victim of a BigPharma purge? Are “liquid biopsies” useful for predicting recurrences, as well as guiding therapy, for cancer? Nighttime smartphone by adolescents surges, eroding kids' sleep needs; Persistent itch may require an “all of the above” approach to break its vicious cycle—could topical vitamin B12 provide an answer? Study critiques research methods that fast-tracked new Alzheimer's drugs.

If you're struggling with dyshidrotic eczema and stuck in the cycle of restrictive diets, expensive creams, and an endless search for answers, this episode offers a fresh perspective. Discover why hand eczema is connected to deeper issues like gut health imbalances, nutrient deficiencies, and immune system dysfunction, rather than just blaming it all on food sensitivities.In this conversation, I explore how common approaches to hand eczema can actually make your rash worse, along with practical insights into what steps support healing. If you've had enough of cracked, itchy, painful, or constantly flaring hands, this episode is for you!⭐️Mentioned in This Episode:- See all the references

In this episode of Wholistic Living, we dive into the powerful connection between myrosinase, gut health, eczema, inflammation, detoxification, and the microbiome. Learn why cruciferous vegetables like broccoli, kale, arugula, cabbage, and broccoli sprouts may not provide their full benefits if the enzyme myrosinase is lacking or destroyed through cooking and poor gut health. We explore how low myrosinase activity on stool testing may reflect dysbiosis, poor microbial diversity, chronic inflammation, mold exposure, antibiotic damage, sluggish bile flow, and impaired detoxification pathways. Discover how this impacts sulforaphane production, NRF2 activation, glutathione, histamine intolerance, hormone balance, liver detoxification, autoimmune conditions, eczema, psoriasis, and skin inflammation. You'll also learn practical ways to naturally increase sulforaphane activation, preserve myrosinase in foods, support gut bacteria involved in glucosinolate metabolism, and improve detoxification through nutrition and lifestyle.Topics covered:What myrosinase is and why it mattersLow myrosinase on stool tests explainedSulforaphane, NRF2, and glutathioneEczema, psoriasis, and chronic inflammationGut dysbiosis and detoxificationMold illness and histamine intoleranceHow cooking affects broccoli and cruciferous vegetablesBroccoli sprouts, mustard seed powder, and sulfur-rich foodsHormone balance, estrogen detox, and liver healthIf you struggle with eczema, skin issues, autoimmune symptoms, histamine reactions, poor detoxification, gut problems, or chronic inflammation, this episode is packed with science-backed holistic insights you do not want to miss.Equip Grass fed protein: www.equipfoods.com/MARLAWork with me: https://holisticspring.com/contactInstagram: www.instagram.com/wholistichomeopath

Description: "When joint pain is present, the diagnosis of psoriatic arthritis needs to be made as soon as possible, ideally within six months to limit joint inflammation" Dr. Vinod Chandran mentions as he discusses efforts to identify a diagnostic test for those at risk of developing psoriatic arthritis.          Join host Jeff Brown as he speaks with leading rheumatologist and clinician scientist Dr. Vinod Chandran, Director of the Gladman Krembil Psoriatic Arthritis Program, Schroeder Arthritis Institute, University Health Network and the Departments of Medicine, Laboratory Medicine and Pathobiology, and the Institute of Medical Science at the University of Toronto to learn more about the progress and promising results towards developing a psoriatic arthritis diagnostic test through multi-omic assays and identifying the distinct differences between psoriasis and psoriatic arthritis.  This episode provides an update on the progress to date of the NPF PsA Diagnostic Test grant initiative which has shown promising results with a potential test entering prospective study in multiple sites soon.   Thank you to Johnson and Johnson for their support of this program activity. Timestamps: (0:00)          Intro to Psoriasis Uncovered & guest welcome rheumatologist Dr. Vinod Chandran.    (0:52)          It is challenging to diagnose psoriatic arthritis with many factors leading to a delay in diagnosis. (4:56)          The start of Dr. Chandran's involvement with the PsA Diagnostic Test Grant project.   (7:55)          The different types of omics and the definition of multi-omic. (9:57)          How the multi-omic approach is used to find biomarkers relative to a specific disease pattern. (11:08)        Development of a predictive or prevention-based test using gene expression.      (13:46)        First year results identify 200 markers across different omic approaches that distinguish psoriatic arthritis from psoriasis.    (14:58)        The significance of MRNA vs mIcroRNA's use in development of a diagnostic test and how critical that is to dissemination of a                     potential test. (17:08)        Identifying the skin-joint axis in relation to different types of arthritis. (20:20)        Next steps to moving the diagnostic test research forward as a prospective study in multiple sites and the cost effectiveness of                  delivering the test.   (23:13)        If you have psoriasis, musculoskeletal, back, and joint pain think of psoriatic arthritis and be diagnosed early to maintain a good                 quality of life. Key Takeaways: ·       Given challenges associated with diagnosing psoriatic arthritis and the impact on quality of life, in 2019 NPF launched the PsA Diagnostic Test Grant project with the goal of developing an early stage test that would identify and diagnose those with psoriatic arthritis before debilitating  joint damage begins.   ·       Progress towards a PsA Diagnostic Test includes the study of multi-omic data sets where 200 distinct biomarkers have been identified leading to a greater understanding of the different pathways between psoriatic arthritis, psoriasis, and the skin joint axis.  ·       A potential diagnostic test is now moving towards the prospective study phase. Until the test is available and if joint pain is present and you have psoriasis, ask your health care provider if it could be psoriatic arthritis and treat appropriately.  Guest Bio: Vinod Chandran, MBBS, MD, DM, PhD is a rheumatologist, clinician scientist, and Director of the Gladman Krembil Psoriatic Arthritis Program, Schroeder Arthritis Institute, University Health Network and the Departments of Medicine, Laboratory Medicine and Pathobiology, and the Institute of Medical Science at the University of Toronto where he is also a Professor of Medicine. His specialties include internal medicine, immunology, rheumatology, and genetic epidemiology. His research focus is on the development of biomarker-based strategies to improve early diagnosis and prognosis of psoriasis and psoriatic arthritis, identification of new treatment targets especially for those who do not respond to current therapies, and strategies to reduce the impact of disease. Dr. Chandran is a Co-Vice President of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis or GRAPPA. He is an active collaborator in a multi-center research consortia such as the International Psoriasis and Arthritis Research Team and the Spondyloarthritis Research Consortium of Canada. Dr. Chandran is the recipient of research funding from the National Psoriasis Foundation for his work in identifying a "Multi-omic Diagnostic Test for PsA in Psoriasis Patients". Resources: "Understanding the NPF Psoriatic Arthritis Diagnostic Test Grant Outcomes" Advance Online. February 18, 2026.  "Managing Chronic Pain with Psoriatic Arthritis" Psoriasis Uncovered podcast episode with physiatrist Dr. Erin Maslowski, LB Herbert who lives with psoriatic disease, and moderator Susan McClelland-Tobert, a retired pediatric cardiologist who also lives with psoriatic disease. Glossary of terms: mRNA: Messenger RNA carries protein information or instructions from the DNA in a cell's nucleus to the cell's interior where the sequence is read and translated into corresponding amino acids for growing protein chains. Micro-RNA (miRNA):  Micro-RNA act as the regulator. They are short and bind to specific target mRNA's to degrade or inhibit production of protein. 

What comes first: the obesity or the skin inflammation?  We've got just the expert to help us find out. This week, we're joined by Dr. Ganary Dabiri as she walks us through the relationship of obesity and the skin. Listen in as she discusses skin diseases, how to use "people first" language, and the clinical possibilities of GLP-1 medications. Each Thursday, join Dr. Raja and Dr. Hadar, board-certified dermatologists, as they share the latest evidence-based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com. Dr. Ganary Dabiri is double board-certified in Dermatology and in Obesity Medicine. She earned her graduate and medical degree from Albany Medical College. She completed her Dermatology Residency at Roger Williams Medical Center. In 2024 she completed her requirements and obtained board certification in Obesity Medicine. Dr. Dabiri is an adjunct assistant professor at Albany Medical College. She works in private practice in Milford, Massachusetts. In 2024, Dr. Dabiri started the first Skin Inflammation and Obesity Medicine Specialty Clinic in Massachusetts. This comprehensive clinic focuses on and treats patients not only for their chronic inflammatory dermatologic condition such as Psoriasis, Hidradenitis Suppurativa, PCOS, and Atopic Dermatitis but treats their concurrent obesity. Since the inception of this clinic, she has helped numerous patients achieve clearer skin, improve their joint health, but equally if not more importantly - improve their overall health.

Could GLP-1 medications be the missing piece in treating inflammatory skin disease? In this episode of Science is Skin, Dr. Ted Lain sits down with Dr. Lindsey Bordone — former Columbia University associate professor of dermatology, now in private practice at Bordone Dermatology in Scottsdale, Arizona — for a deep dive into metabolic disease and the skin. Dr. Bordone was among the first dermatologists to prescribe GLP-1 agonists for her patients, and in this conversation she explains exactly why. From the link between hyperinsulinemia and chronic inflammation to the visible skin signs of insulin resistance — skin tags, acanthosis nigricans, forearm hair loss — she makes the case that dermatologists are uniquely positioned to catch metabolic disease before any other specialty. Dr. Bordone walks through how she uses tirzepatide (Mounjaro/Zepbound), semaglutide (Ozempic/Wegovy), and the emerging triple-G drug retatrutide, including her lab protocols, dosing philosophy, how to manage GI side effects, and the surprising interaction between GLP-1s and estrogen therapy. In this episode: Why high BMI reduces biologic efficacy in psoriasis patients How to check fasting insulin (HOMA-IR) and why most physicians aren't doing it Skin signs of insulin resistance: skin tags, forearm hair loss, and neck skin thickening Tirzepatide vs. semaglutide vs. retatrutide — how to choose and when Retatrutide's remarkable 93% fatty liver clearance rate in clinical trials The truth about sarcopenia and muscle loss on GLP-1 medications Dosing protocols, side effect management, and when NOT to escalate quickly Protein intake recommendations during active weight loss Estrogen and GLP-1 synergy — what dermatologists need to know Lab work to run before and during GLP-1 therapy How to build an insurance case for continued medication coverage Resources mentioned: HOMA-IR fasting insulin/glucose testing AAD resources on metabolic dermatology Bordone Dermatology — Scottsdale, Arizona Enjoyed this episode? Share it with a colleague and leave us a five-star review. Subscribe so you never miss an episode of Science is Skin. To watch this and other episodes, be sure to check out our YouTube page DISCLAIMER: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/WNB865. CME/AAPA credit will be available until April 21, 2027.A New Era in Psoriasis Care With Oral IL-23 Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/WNB865. CME/AAPA credit will be available until April 21, 2027.A New Era in Psoriasis Care With Oral IL-23 Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/WNB865. CME/AAPA credit will be available until April 21, 2027.A New Era in Psoriasis Care With Oral IL-23 Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/WNB865. CME/AAPA credit will be available until April 21, 2027.A New Era in Psoriasis Care With Oral IL-23 Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/WNB865. CME/AAPA credit will be available until April 21, 2027.A New Era in Psoriasis Care With Oral IL-23 Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

Description: "What is metabolic disease and why do I have it on top of psoriatic disease?" Hear dermatologist Dr. Ronald Prussick and registered dietitian Danielle Cahalan explore this collision of diseases and how you can take control to help reduce the impact of inflammation.           Join host Corinne Rutkowski as she discusses why metabolic disease occurs with psoriasis and psoriatic arthritis and what can be done to improve overall health with dermatologist and Vice Chair of the NPF Medical Board, Dr. Ronald Prussick from Washington Dermatology Center in Rockville and Frederick, MD, and Danielle Cahalan, a registered dietitian and coach with All Access Dietitians. Listen as they also discuss the four pillars of health, the latest evidence around use of the Mediterranean Diet with psoriatic disease, key nutrients that impact overall health from omega 3's, polyphenols, and fiber, to making small sustainable changes.  This episode offers information to help explain the connection between metabolic and psoriatic disease and what can be done to decrease health risks associated with both diseases through sustainable changes. Timestamps: (0:00)  Intro to Psoriasis Uncovered & guest welcome dermatologist Dr. Ronald Prussick and registered dietitiand and coach                  Danielle Cahalan.                                                                                              (1:27)  Definition of metabolic disease and why the risk is higher among those with psoriasis or psoriatic arthritis. (3:11)  How this bi-directional relationship impacts the management of psoriasis and psoriatic arthritis. (6:54)  The four pillars of health that can be used to reduce the risk of metabolic disease.   (11:17) Does an anti-inflammatory diet exist? (13:46) What is the Mediterranean diet and the foods that are typically included. (16:32) The impact of the Mediterranean diet on systemic inflammation, metabolic health, and severity of psoriatic disease. (21:03) The three types of healthy fats – what they are, how they work, and where to find them. (24:50) The high polyphenol Mediterranean diet from what that means to choosing nutrient dense, colorful foods. (28:04) The koebnerization of the gut microbiome and the impact of the Mediterranean diet and high fiber. (30:59) The DASH diet in combination with the Mediterranean diet lowers oxidative stress and inflammation. (33:14) Sustainability of the Mediterranean diet and flexing behavioral health changes long term.  (37:43) Start with small habit changes and then build from there to have an impact on your metabolic health.  Key Takeaways: ·       Research shows a bi-directional relationship between psoriasis and excess body weight leading to increasing severity of disease, decrease in treatment effectiveness, and the development of metabolic syndrome, a group of conditions which together raise the risk of coronary heart disease, stroke, and diabetes. ·       What you choose to eat can make an impact in managing inflammatory markers, metabolic health to increase insulin sensitivity, decrease high blood pressure, improve lipids and the gut microbiome, as well as support neuro protection and decrease cognitive decline. ·       Create small sustainable habits that make positive changes to your immune system and gradually work towards building a foundation that benefits your overall health. Guest Bios: Renowned dermatologist Ronald Prussick, M.D. is the Medical Director of the Washington Dermatology Center in Rockville and Fredrick, Maryland where he specializes in the treatment of psoriasis along with other diseases of the skin, hair, and nails with the latest technology and products. Dr. Prussick is also a Clinical Associate Professor in Dermatology at George Washington University in Washington, D.C.. Dr. Prussick has a research interest in the impact of diet on psoriatic disease and metabolic health. He first became interested after being involved in Dr. Joel Gelfand and Dr. Nehal Mehta's work in vascular inflammation trials using FDG-PET?CT scans to view systemic and cardiovascular inflammation associated with psoriatic disease. Dr. Prussick also participated in the development of the 2018 Dietary Recommendations for Adults with Psoriasis or Psoriatic Arthritis from the Medical Board of the NPF, which offered a review of studies addressing the impact of dietary interventions in people with psoriasis and psoriatic arthritis. Dr. Prussick is Vice Chair of the NPF Medical Board which provides clinical direction, treatment guidance, and provides education oversight to the organization and its Executive leaders. Danielle Cahalan, MS, RDN is a licensed and registered dietitian and coach with All Access Dietitians which offers virtual nutrition support services in AZ, CA, CO, CT, FL, IL, IN, MA, MO, MT, NJ, NY, NC, OR, PA, SC, TX, VA, WA, WI, and WY. All Access Dietitians infuses the science of motivation, habit formation, and sustainable behavior change into every session that addresses weight management and metabolic health, to women's health and digestive support. Danielle's primary focus during sessions is to help her clients find that intersection between enjoyment and satisfaction with their food choices that also support their health through sustenance. It's about finding that balance between feeling empowered, energized, and confident in the ability to make decisions that impact health, wellness, and longevity. Resources: "Mediterranean Diet Pyramid: Guidelines for Healthy Eating" © 2009 Oldways Preservation and Exchange Trust www.oldwayspt.org and UCSF Weill Institute for Neurosciences Memory and Aging Center. DASH Eating Plan (Dietary Approaches to Stop Hypertension). February 25, 2026. NIH (National Heart, Lung, and Blood Institute)  Mediterranean Diet and Patients With Psoriasis: The MEDIPSO Randomized Clinical Trial. AMA Dermatology . Dec. 1, 2025  The Mediterranean Diet as a Potential Solution to the Gut Microbiome Dysbiosis in Psoriasis Patients Journal of Psoriasis and Psoriatic Arthritis 2024 Jan 9.

La psoriasis pediátrica es una condición que no sólo afecta la piel, sino también se asocia a comorbilidades significativas y a una disminución de la calidad de vida de los niños y sus familias. En este episodio profundizamos en el tema con una experta en la materia, desde cómo se manifiesta la psoriasis pediátrica, sus potenciales causas y alternativas de tratamientos. Nos acompaña la Dra. Paula Luna desde Buenos Aires, Argentina. La Dra. Luna es dermatóloga y dermatóloga pediatra en el Hospital Alemán en Buenos Aires, Argentina, donde también dirige la beca en psoriasis y otras enfermedades inflamatorias. Se desempeña como secretaria general de la Sociedad Argentina de Psoriasis y de la Sociedad de Dermatología Pediátrica para América Latina. Después de completar su residencia en dermatología y de ejercer como jefa de residentes, la Dra. Luna realizó la subespecialidad de tres años en dermatología pediátrica en el Hospital Ramos Mejía de Buenos Aires. Instagram: @‌drapauluna ¿Tienes algún comentario sobre este episodio o sugerencias de temas para un futuro podcast?  Escríbenos a pediatrasenlinea@childrenscolorado.org.

The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use, efficacy and side effects.  Features Dr. Jack Cush, Editor at RheumNow.com. Show Notes: Chinese target emulation trial of MDA-5+, dermatomyositis w/ ILD. 106 Rx w/ UPA & 328 w/ TOFA. 6-month lung transplantation-free survival 72% vs 67% (UPA v TOFA). UPA non-inferior to TOFA in MDA5+DM-ILD https://t.co/BBAfbM06AM In 2025 DTC TV ad spending by top 10 incr to $2.67 billion (up from $2.1 B). Rheum Drugs in top 3: 1. Skyrizi $440 million 2. Tremfya $431 M 3. Rinvoq $376 M https://t.co/EsWgUqUy9Z 2. Dermatology Salaries 2025 – Dermatology is top 10 at $448K according to Medscape; expected to go down -1% in 2026; derms made up 2% of survey group 37K MDs 3. Itch is common in Scleroderma (SSc) and not related to Dz duration. Study of 2173 Pts (~20K itch assessments), 87 F; mean age 55 yrs; 40% w/ diffuse SSc. Itch (moderate 4/10) seen in ~35% at all times https://t.co/QnT8d0xA5Z 4. Asia-Pacific Lupus study of Mucocutaneous activity (MC-A) in 4102 SLE pts. 36% had MC-A (rash 1055; alopecia 731; m ulcers 352); 15% persistently. MC-A assoc w/ W, smoking, +serologies, vasculitis, myositis, serositis, nephritis, NP-SLE https://buff.ly/D5fXJdY 5. Predictors of Calcinosis Cutis in Systemic Sclerosis   6. AFFINITY Study - Combination Biologic Therapy in PsA A pilot trial assessed the efficacy and safety of the guselkumab+golimumab (COMBO) combination versus GUS monotherapy in active PsA (failing a prior tumor necrosis factor inhibitor (TNFi-IR) and showed superiority in ACR 50 https://t.co/f2CB8FnZMB 7. AAD 2026 Annual Mtg presents new data on another TYK2 inhibitor. In 2 phase 3 RCTs (ONWARD1 ONWARD2) envudeucitinib was superior to placebo & apremilast in 1700 plaque psoriasis pts https://t.co/DPlzDw5m7N 8. Among 1074 #PsA tested annually, RF positivity was found in 16.1% overall (5.1% RF+ at baseline). RF+ rediced odds of MDA (OR 0.53) w/ incr risk of bDMARD discontinuation (OR 2.65) https://buff.ly/BsM7NKQ 9. The National Psoriasis Foundation Primer on GLP-1 Receptor Agonists in Psoriasis - Review 10. Ixekizumab With Tirzepatide Efficacy in Obese Psoriatic Arthritis 11. Brepocitinib in Dermatomyositis

Bloating after meals, constipation, or sudden urgency to run to the bathroom are often brushed off as normal, but they can be signs of irritable bowel syndrome. In this episode, we unpack why IBS is often treated as a label to justify medications rather than a sign pointing you to issues brewing under the surface.Joining me today is Dr. Izabella Wentz, an integrative pharmacist, thyroid expert, and bestselling author known for helping people uncover the root causes of chronic health issues.So if you have tried elimination diets, probiotics, or leaky gut supplements without lasting relief, this conversation is for you!⭐️Mentioned in This Episode:- My FAV gut support

Please visit answersincme.com/860/IME-018263-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by April W. Armstrong, MD, MPH and Lawrence J. Green, MD. In this activity, experts in psoriasis review the latest evidence on approved and emerging TYK2 inhibitors for patients with moderate to severe plaque psoriasis. Upon completion of this activity, participants should be better able to: Recognize unmet needs in the treatment of patients with moderate to severe plaque psoriasis; Differentiate TYK2 signaling from JAK pathways and their relevance to clinical practice; and Review clinical trial data on approved and emerging TYK2 inhibitors for patients with moderate to severe plaque psoriasis.

In this episode, Drs. Nilasha Ghosh and Anne Bass discuss immune-related adverse events from immune checkpoint inhibitors, focusing on psoriasis and psoriatic arthritis. They review early clinical recognition, epidemiology, and findings from a multicenter observational study evaluating apremilast, including patient characteristics, outcomes, and key limitations. The conversation also highlights insights from the HSS Checkpoint Inhibitor–Associated Arthritis Registry, the need for greater precision in rheumatology, and practical perspectives on mentorship and career development for emerging clinician–scientists.  Use of Apremilast for the Treatment of Immune Checkpoint Inhibitor Psoriasis and Psoriatic Arthritis 

With so many options available to treat psoriasis and psoriatic arthritis across age groups, treatment selection must be made on an individualized basis. DEF Biologic & Small Molecule CME Bootcamp faculty members Joe Gorelick, MSN, FNP-C, Kara Gooding, MMS, PA-C, and Andrea Nguyen, DMSc, MPAS, PA-C discuss case presentations. Plus, an update on PRP from Gilly Munivalli, MD and rosacea tips from Wendy Cantrell, DNP, CRNP.Like what you're hearing? Want to learn more about the Dermatology Education Foundation? Explore assets and resources on our website.

Description: Coping with psoriasis can be challenging when your routine changes. Hear NPF Youth Ambassadors Aditi, Alyssa, and Pierce offer what they do to overcome such challenges when out of their routine.            Join host Kaleigh Welch as she discusses tips for coping with changes that occur when traveling to visit family or friends, going on vacation, camping, or a change in schedule with three amazing NPF Youth Ambassadors Aditi, Alyssa, and Pierce who live with psoriasis. Hear their story from challenges with their initial diagnosis, struggles with insecurities, whether they choose to inform others, and what they do to manage their disease and stress while living their life with confidence to pursue their chosen activities  no matter if their routine changes.  This episode features how 3 NPF Youth Ambassadors overcome challenges when out of their routine and how they respond while managing their psoriasis.   (0:00) Intro to Psoriasis Uncovered & welcome to guests Youth Ambassadors Aditi, Alyssa, and Pierce. (0:55) Overcoming challenges from diagnosis, finding the right treatment, to making choices impacted by living with psoriasis.        (5:44) Tips for what to do and pack when traveling for activities that disrupt the usual routine. (10:11) Keeping the skin moisturized can be a challenge but find a routine and product that works. (12:38) Preparing for potential triggers that could initiate the Koebner phenomenon and psoriasis. (13:33) Managing the impact of stress when out of the routine or traveling. (16:20) Alyssa's approach to managing fatigue. (16:53) The impact of diet and exercise when managing psoriasis. (18:47) Telling others about psoriasis when staying at a friend's house or hotel. (23:36) Our number one recommendation for when being out of your routine.  (25:39) Be confident about who you are and trust you'll find the right treatment and routine for your psoriasis. Key Takeaways: ·       Being out of your normal routine whether traveling on vacation or for work, camping, staying at a hotel or with family or friends can present challenges to managing your psoriasis.   ·       Preparing in advance by anticipating medication or over-the-counter needs, telling others, and asking for help can reduce the impact of challenges due to a change in routine.   ·       Be confident about who you are, find a treatment that works, and learn to live successfully with your psoriasis.   Guest Bios: Aditi enjoys Carnatic singing, violin, figure skating, and participating in Model UN where students debate global issues, learn diplomacy, international relations, and public speaking. Aditi was diagnosed with psoriasis at 10 years old and has used topicals to manage her disease along with diet, exercise and stress management. Prior to becoming a Youth Ambassador she had never met anyone with psoriasis. She plans to pursue a career in dermatology.  Alyssa is relatively new to the NPF Youth Ambassador program, joining in 2025 to connect with others who also live with psoriasis. Her diagnosis process was challenging and eventually she was diagnosed with guttate psoriasis after being improperly diagnosed and given treatments that didn't fully clear her psoriasis. This experience changed her life both physically and emotionally. Alyssa is a busy student-athlete serving as a member of her school's varsity cheer team and being a star pitcher for her school's softball team.  Pierce connected with NPF right after being diagnosed with moderate to severe plaque psoriasis in 2024 which covered over half of his body. Together with his mother they learned more about the disease and management with various treatment options from NPF, quickly learning what worked and what didn't. Per Pierce "it was horrible dealing with it for a while because I couldn't hide the plaques."  After facing challenges with step therapy and eventually traveling to the Mayo Clinic he found the treatment he needed to help clear his skin. Pierce is very active in golf playing at least 5 days a week. He currently plays for his high school team, the Louisiana Junior Golf Tour, and the American Junior Golf Association (AJGA).  Pierce also became a Youth Ambassador to meet others with psoriatic disease. Resources: -Meet other teens who have psoriatic disease. Become a Youth Ambassador -"Traveling Near and Far With Psoriatic Disease" podcast episode. -"Moisturizing Sensitive Skin" Advance Online. June 11, 2025. 

If there are five people in a room with eczema, they're probably all dealing with it for completely different reasons.And that's something we don't talk about enough.Eczema, acne, psoriasis… these are rarely just skin issues. They're often a reflection of what's happening inside the body, particularly in the gut.So instead of just asking what to put on your skin, this episode is about asking a better question. What's actually driving this underneath?My guest today is Farzanah Nasser, a registered nutritionist and certified functional medicine practitioner specialising in gut health, immune health and chronic skin conditions.She works with people every day, dealing with long-standing skin issues using a practical, gut-first approach.She's also the author of “The Everyday High-Fibre Plan”, full of simple, gut-friendly recipes… including those cookies on the table if you're watching on YouTube

It probably doesn't surprise you that HS (hidradenitis suppurativa) is much more than just a skin condition. There is an increasing body of research showing how HS is linked to immune dysfunction, gut health, liver problems, hormone imbalances, and so much more that often goes overlooked in conventional medical care.In this episode, I'm diving into the links between Hidradenitis suppurativa and autoimmune disease, liver health, thyroid dysfunction, and gut health, so you can spot red flags and get help sooner!⭐️Mentioned in This Episode:- See all the references

Dermoscopy master class - with Dr. Michael Christopher! [⁠article⁠]The plumage sign in dermoscopy: pigmented SCCis [⁠article⁠] Highlights from the AAD -Icotrokinra for psoriasis [⁠article⁠] Learn more from Dr. Christopher! Instagram: @michael_christopher_mdCheck out Luke's Urticaria CME experience! ⁠aaaaicsu.gathered.com/invite/KQe1wPZbJY⁠ Learn moreabout the U of U Dermatology ECHO model! ⁠physicians.utah.edu/echo/dermatology-primarycare⁠ Want to donate to the cause? Do so here!Donate to the podcast: ⁠⁠uofuhealth.org/dermasphere⁠⁠Check out our video content on YouTube:⁠⁠www.youtube.com/@dermaspherepodcast⁠⁠and VuMedi!: ⁠⁠www.vumedi.com/channel/dermasphere/⁠⁠The University of Utah's DermatologyECHO: ⁠⁠⁠physicians.utah.edu/echo/dermatology-primarycare⁠⁠ -Connect with us!- Web: ⁠⁠⁠dermaspherepodcast.com/⁠⁠⁠ - Twitter: @⁠DermaspherePC⁠- Instagram: dermaspherepodcast- Facebook: ⁠⁠www.facebook.com/DermaspherePodcast/⁠⁠- Check out Luke and Michelle's other podcast,SkinCast! ⁠⁠⁠healthcare.utah.edu/dermatology/skincast/⁠⁠⁠ Luke and Michelle report no significant conflicts of interest… BUT check out our friends at:- ⁠Kikoxp.com ⁠(a social platform for doctors to share knowledge)- ⁠⁠⁠www.levelex.com/games/top-derm⁠⁠⁠ (A free dermatology game to learn more dermatology!

Dermoscopy master class - with Dr. Michael Christopher! [article]The plumage sign in dermoscopy: pigmented SCCis [article] Highlights from the AAD -Icotrokinra for psoriasis [article] Learn more from Dr. Christopher! Instagram: @michael_christopher_mdCheck out Luke's Urticaria CME experience! aaaaicsu.gathered.com/invite/KQe1wPZbJY Learn moreabout the U of U Dermatology ECHO model! physicians.utah.edu/echo/dermatology-primarycare Want to donate to the cause? Do so here!Donate to the podcast: ⁠uofuhealth.org/dermasphere⁠Check out our video content on YouTube:⁠www.youtube.com/@dermaspherepodcast⁠and VuMedi!: ⁠www.vumedi.com/channel/dermasphere/⁠The University of Utah's DermatologyECHO: ⁠⁠physicians.utah.edu/echo/dermatology-primarycare⁠ -Connect with us!- Web: ⁠⁠dermaspherepodcast.com/⁠⁠ - Twitter: @⁠DermaspherePC⁠- Instagram: dermaspherepodcast- Facebook: ⁠www.facebook.com/DermaspherePodcast/⁠- Check out Luke and Michelle's other podcast,SkinCast! ⁠⁠healthcare.utah.edu/dermatology/skincast/⁠⁠ Luke and Michelle report no significant conflicts of interest… BUT check out our friends at:- ⁠Kikoxp.com ⁠(a social platform for doctors to share knowledge)- ⁠⁠www.levelex.com/games/top-derm⁠⁠ (A free dermatology game to learn more dermatology!

Persistent drool rash can be more than just a messy phase. In this episode, we explore how red, irritated cheeks, especially when they flare at certain times of day, may be early clues that a baby's skin barrier is struggling and that deeper eczema-related issues could be developing.We also unpack how signs like cradle cap, colic, diaper rash, flushing with foods, and mucus in stools can fit into a bigger picture. Tune in to learn how to tell the difference between a drool rash, an eczema flare, and a possible allergic reaction, so you can feel more confident about what your baby's skin may be trying to tell you.My guest, Jennifer Brand, MS, MPH, CNS, LDN, is a clinical nutritionist who helps babies and children with chronic rashes get to the root causes of their skin issues. Known for her pediatric skin-focused approach, she is passionate about helping families support healthy skin through her signature method, Rashes Be Gone.⭐️Mentioned in This Episode:- See all the references

Topical steroid withdrawal syndrome is finally getting the serious attention it deserves. In this episode, talk about the first published criteria to help doctors diagnose TSW (also known as red skin syndrome) and why it will help validate the experience of people who have been dismissed, misdiagnosed, or told they simply have severe eczema. We also dig into the growing gap between patient experience and conventional dermatology, and why that disconnect has left so many people searching for answers on their own.Dr. Olivia Hsu Friedman, DACM, L.Ac, Dipl.OM, joins me to discuss this and more! She is the owner of Amethyst Holistic Skin Solutions and brings extensive training in acupuncture, Chinese medicine, and dermatology to this timely discussion.⭐️Mentioned in This Episode:- See all the references